P-215: A phase I/II study of Pomalidomide, Ixazomib, Clarithromycin and Dexamethasone (PICd) in patients with relapsed or refractory Multiple Myeloma (RRMM)
Titel:
P-215: A phase I/II study of Pomalidomide, Ixazomib, Clarithromycin and Dexamethasone (PICd) in patients with relapsed or refractory Multiple Myeloma (RRMM)
Auteur:
Rosenberg, Aaron Muñoz, Meilen Costello, Caitlin Brem, Elizabeth Reid, Erin Maverakis, Emanual Kaesberg, Paul Lee, Lisa Tuscano, Joseph Abedi, Mehrdad